No claims are made regarding the diagnosis, treatment, or prevention of any disease or condition
In human clinical use, reported side effects are generally mild and transient: Mild injection site redness or discomfort (resolves within hours) Transient nausea in some patients, particularly early in the protocol Mild dizziness or light-headedness (rare, typically dose-related) Temporary fatigue in the first few days (often a sign of active tissue remodeling) No significant systemic toxicity, organ damage, hormonal suppression, or addiction potential has been documented in the published literature
2010 Sep;28(9):1155-61
Journal of Molecular Medicine , 95(3), 323333
Andrea M
It has FDA Angiogenesis Peptides Require Strict Cycling Angiogenesis peptides (BPC-157, TB-500) stimulate new blood vessel growth powerful for tissue repair but potentially harmful if used continuously 5-Amino-1MQ Fat Metabolism Peptide 5-Amino-1MQ inhibits NNMT (nicotinamide N-methyltransferase), an enzyme involved in fat cell metabolism
